Evidence map›Paper›PMID 19890022›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2009

Comparison of simvastatin and metformin in treatment of polycystic ovary syndrome: prospective randomized trial.

Beata Banaszewska, Leszek Pawelczyk, Robert Z Spaczynski, Antoni J Duleba

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 8 pooled it
10.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 8 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. The Effect of Statins on Levels of Dehydroepiandrosterone (DHEA) in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.The Journal of clinical endocrinology and metabolism · 2013 · on this map
    Guideline
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome.Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2012
    Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Beata BanaszewskaDivision of Infertility and Reproductive Endocrinology, Department of Gynecology, Obstetrics, and Gynecological Oncology, Poznan University of Medical Sciences, 60-535 Poznan, Poland.
Leszek Pawelczyk
Robert Z Spaczynski
Antoni J Duleba
Poznan University of Medical Sciences · PLUniversity of California, Davis · US

Funding

Mevalonate pathway and thecal-interstitial functionR01HD050656 · NICHD · YALE UNIVERSITY · PI DULEBA, ANTONI J · 2007 to 2011
$1.6M
NICHD NIH HHS R01 HD050656
6 · The paper itself

Abstract

contextPolycystic ovary syndrome (PCOS) is characterized by ovarian dysfunction and hyperandrogenism; it is also associated with increased cardiovascular risks such as adverse lipid profile and endothelial dysfunction. Metformin and, more recently, statins have been shown to improve endocrine and metabolic aspects of PCOS.

objectiveThe aim of the study was to compare effects of simvastatin and metformin on PCOS.

designIn a prospective trial, women with PCOS (n = 136) were randomized to simvastatin (S), metformin (M), or simvastatin plus metformin (SM) groups. Evaluations were performed at baseline and after 3 months.

settingThe study was conducted at an academic medical center. PRIMARY OUTCOME: The change of serum total testosterone was measured.

resultsThe study was completed by 113 subjects. Total testosterone decreased significantly and comparably in all groups: by 17.1, 13.6, and 15.1%, respectively, in the S, M, and SM groups. Significant decreases were also observed in all groups with respect to body mass index, C-reactive protein, and soluble vascular cell adhesion molecule-1. DHEAS declined significantly only in the S group. None of the treatments were associated with significant changes in LH or FSH. Total cholesterol and low-density lipoprotein cholesterol significantly declined only in S and SM groups.

conclusionsSimvastatin treatment was superior to metformin alone, whereas a combination of simvastatin and metformin was not significantly superior to simvastatin alone.

Indexed as

AdultCardiovascular DiseasesDehydroepiandrosterone SulfateDrug Therapy, CombinationFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHyperandrogenismHypoglycemic AgentsLipidsMetforminPolycystic Ovary SyndromeProspective StudiesRisk FactorsSex Hormone-Binding GlobulinSimvastatinDehydroepiandrosterone SulfateHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsLipidsMetforminSex Hormone-Binding GlobulinSimvastatinTestosterone

Identifiers

PMID19890022
PMCPMC2795658
OpenAlexW2124724942

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.